Our current observation that anti-TNFα and anti-IL-1 therapies had no effect on increased circulating IL-17 levels in rat AIA supports the hypothesis that IL-17 acts upstream of IL-1 and TNF in experimental arthritis [59,60]. The gene discussed is IL1B; the disease is Arthritis.